Hemosate Ultra Hs3125 6.91 g (Citric Acid SOLUTION) 6.91 G

HEMOSATE ULTRA HS3125 6.91 G is a citric acid solution designed for haemodialysis. This product is manufactured by Chief Medical Supplies Ltd. in Canada, ensuring quality and reliability for medical use.

Strength

6.91 G

Manufacturer / TM Owner

CHIEF MEDICAL SUPPLIES LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HEMOSATE ULTRA HS3125 6.91 G is primarily used in haemodialysis procedures. Citric acid solutions like this one are often utilized to maintain the acidity of the dialysate, which is crucial for effective dialysis. This product is specifically formulated to support the haemodialysis process, ensuring optimal performance and patient safety.

Side Effects

When used as directed, HEMOSATE ULTRA HS3125 6.91 G helps to regulate the pH balance in the dialysate. This can contribute to the overall effectiveness of the haemodialysis treatment, promoting better patient outcomes. Users may notice improved dialysis efficiency when this solution is incorporated into the process.

Precautions & Warnings

It is important to handle HEMOSATE ULTRA HS3125 6.91 G with care, following all safety guidelines provided by the manufacturer. Ensure that the solution is stored properly and used within its recommended shelf life. Always consult healthcare professionals for specific instructions and precautions related to haemodialysis procedures.

Avoid Interactions

Citric acid solutions like HEMOSATE ULTRA HS3125 6.91 G may interact with certain medications or substances. It is advisable to check with a healthcare provider to ensure compatibility with other treatments or supplements. Always follow the manufacturer's guidelines to avoid potential interactions.

Frequently Asked Questions

HEMOSATE ULTRA HS3125 6.91 G is used in haemodialysis to maintain the acidity of the dialysate, supporting effective dialysis.

Store HEMOSATE ULTRA HS3125 6.91 G according to the manufacturer's instructions, typically in a cool, dry place away from direct sunlight.

Consult a healthcare provider to ensure compatibility with other medications or treatments before using HEMOSATE ULTRA HS3125 6.91 G.

HEMOSATE ULTRA HS3125 6.91 G helps regulate the pH balance in the dialysate, contributing to the effectiveness of haemodialysis.

HEMOSATE ULTRA HS3125 6.91 G is manufactured by Chief Medical Supplies Ltd. in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.